Clinical Trials in Philadelphia

Showing 12741-12760 of 20,904 trials

Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis

NCT01318902

This study will include participants with previously treated systemic relapsed or refractory light-chain (AL) amyloidosis who require further therapy and will be aimed at determining the safety profile and the maximum tolerated dose/recommended phase 2 dose of MLN9078 (Ixazomib) administered orally.

Light-Chain Amyloidosis

Millennium Pharmaceuticals, Inc.27 participantsStarted Apr 2011

Boston, Massachusetts, United States • Boston, Massachusetts, United States • Detroit, Michigan, United States +7 more locations

COMPLETED< 1 mile

Analyses of Human Samples Collected in Clinical Trials

NCT00339664

Cancer patients in clinical trials donate various human samples (e.g., serum, plasma, blood, urine, feces, bile, saliva) for research purposes. The purpose of this study is to conduct further analyses on these existing samples from clinical trials that are being performed outside of, but in collaboration with, the National Cancer Institute.

Leukemia, MyeloidNeoplasm MetastasisLeukemia, Lymphoid+1 more

National Cancer Institute (NCI)2,579 participantsStarted Jul 2003

Washington D.C., District of Columbia, United States • Tampa, Florida, United States • Chicago, Illinois, United States +14 more locations

Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis

Analyses of Human Samples Collected in Clinical Trials

Find Trials by Condition in Philadelphia

Doravirine, Rifapentine and Isoniazid Interaction

Ofatumumab Bendamustine Combination Compared With Bendamustine Monotherapy in Indolent B-cell NHL Unresponsive to Rituxtherapy

Unlock the Cell: Castleman's Disease Flow Cytometry Study

Pazopanib/DCE-MRIs in Renal Cell Carcinoma (RCC)

Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older

A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis

Electrical Stimulation for the Treatment of Post-Amputation Pain Using the SPRINT System

Examining Heart Attacks in Young Women

TAU Opioid Use Outcomes Following Discharge From Detoxification and Short Term Residential Programs Affiliated With CTN-0051

D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions

Safety Study of Eteplirsen to Treat Advanced Stage Duchenne Muscular Dystrophy

Vaccine Therapy in Treating Patients With Breast Cancer

Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Anti-inflammatory Dose Doxycycline in Moderate Papulopustular Rosacea

Standard Root Planing vs. Periodontal Structure Repair Device for Treatment of Pockets Caused by Periodontal Disease

Study of ACTR T Cell Product in Combination With Trastuzumab in Subjects With HER2-Positive Advanced Solid Tumor Cancers

Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder

Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin

Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy